Century Therapeutics appoints Brent Pfeiffenberger as President and CEO, effective Dec 4, 2023

Century Therapeutics, Inc.

Brent Pfeiffenberger appointed CEO and to Board; Gregory Russotti transitions to Chief Technology and Manufacturing Officer.
Pfeiffenberger receives $625K base salary, 55% target bonus, $200K signing bonus, $450K retention bonus, and equity awards.
Equity includes options for 573,691 shares and RSUs covering 1,173,775 shares (Initial RSU) plus $450K value Second RSU.
Russotti's new role carries $525K base salary and 45% annual target bonus; prior interim CEO role ends Dec 4.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brent Pfeiffenberger

President and Chief Executive Officer

IPSC · Century Therapeutics, Inc.

Effective: 2023-12-04
Filed: November 14, 2023, 6:59 PM ET

appointed Brent Pfeiffenberger to serve as the Company’s President and Chief Executive Officer, effective December 4, 2023

Appointed

Brent Pfeiffenberger

member of the Board

IPSC · Century Therapeutics, Inc.

Effective: 2023-12-04
Filed: November 14, 2023, 6:59 PM ET

Dr. Pfeiffenberger was appointed to serve as a member of the Board

Role change

Gregory Russotti

Chief Technology and Manufacturing Officer

IPSC · Century Therapeutics, Inc.

Effective: 2023-12-04
Successor: Brent Pfeiffenberger
Filed: November 14, 2023, 6:59 PM ET

Dr. Russotti will serve as the Company’s Chief Technology and Manufacturing Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brent Pfeiffenberger was appointed as President and Chief Executive Officer at Century Therapeutics, Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

appointed Brent Pfeiffenberger to serve as the Company’s President and Chief Executive Officer, effective December 4, 2023

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Brent Pfeiffenberger was appointed as member of the Board at Century Therapeutics, Inc..

Action: appointed
Role: member of the Board

Exact text from the filing

Dr. Pfeiffenberger was appointed to serve as a member of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Gregory Russotti changed role as Chief Technology and Manufacturing Officer at Century Therapeutics, Inc..

Action: transitions
Role: Chief Technology and Manufacturing Officer

Exact text from the filing

Dr. Russotti will serve as the Company’s Chief Technology and Manufacturing Officer.

View on SEC.gov

Century Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-117704

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.